Skip to main content
SpringerLink
Log in

The Effects of Natural Antioxidants from Tomato Extract in Treated but Uncontrolled Hypertensive Patients

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the effect of adding tomato extract to the treatment regime of moderate hypertensives with uncontrolled blood pressure (BP) levels.

Methods

Fifty four subjects with moderate HT treated with one or two antihypertensive drugs were recruited and 50 entered two double blind cross-over treatment periods of 6 weeks each, with standardized tomato extract or identical placebo. Plasma concentrations of lycopene, nitrite and nitrate were measured and correlated with BP changes.

Results

There was a significant reduction of systolic BP after 6 weeks of tomato extract supplementation, from 145.8 ± 8.7 to 132.2 ± 8.6 mmHg (p < 0.001) and 140.4 ± 13.3 to 128.7 ± 10.4 mmHg (p < 0.001) in the two groups accordingly. Similarly, there was a decline in diastolic BP from 82.1 ± 7.2 to 77.9 ± 6.8 mmHg (p = 0.001) and from 80.1 ± 7.9 to 74.2 ± 8.5 mmHg (p = 0.001). There was no significant change in systolic and diastolic BP during the placebo period. Serum lycopene level increased from 0.11 ± 0.09 at baseline, to 0.30 ± 01.3 μmol/L after tomato extract therapy (p < 0.001). There was a significant correlation between systolic BP and lycopene levels (r = −0.49, p < 0.001).

Conclusions

Tomato extract when added to patients treated with low doses of ACE inhibition, calcium channel blockers or their combination with low dose diuretics, had a clinically significant effect—reduction of BP by more than 10 mmHg systolic and more than 5 mmHg diastolic pressure. No side-effects to treatment were recorded and the compliance with treatment was high. The significant correlation between systolic blood pressure values and level of lycopene suggest the possibility of cause–effect relationships.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560–72.

    Article  PubMed  CAS  Google Scholar 

  2. Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy. Pharmacoepidemiol Drug Saf 2006;15:587–93.

    Article  PubMed  Google Scholar 

  3. Garfield FB, Caro JJ. Compliance and hypertension. Curr Hypertens Rep 1999;1:502–6.

    Article  PubMed  CAS  Google Scholar 

  4. Hassan NB, Hasanah CI, Foong K, Naing L, Awang R, Ismail SB, et al. Identification of psychosocial factors of noncompliance in hypertensive patients. J Hum Hypertens 2006;20:23–9.

    Article  PubMed  CAS  Google Scholar 

  5. Benson S, Vance-Bryan K, Raddatz J. Time to patient discontinuation of antihypertensive drugs in different classes. Am J Health Syst Pharm 2000;57:51–4.

    PubMed  CAS  Google Scholar 

  6. John JH, Ziebland S, Yudkin P, Roe LS, Neil HA. Effects of fruit and vegetable consumption on plasma antioxidant concentrations and blood pressure: a randomised controlled trial. Lancet 2002;359:1969–74.

    Article  PubMed  CAS  Google Scholar 

  7. Gerster H. The potential role of lycopene for human health. J Am Coll Nutr 1997;16:109–26.

    PubMed  CAS  Google Scholar 

  8. Upritchard JE, Sutherland WH, Mann JI. Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care 2000;23:733–8.

    Article  PubMed  CAS  Google Scholar 

  9. Engelhard YN, Gazer B, Paran E. Natural antioxidants from tomato extract reduce blood pressure in patients with grade-1 hypertension: a double-blind, placebo-controlled pilot study. Am Heart J 2006;151:100.

    Article  PubMed  CAS  Google Scholar 

  10. Walfisch Y, Walfisch S, Agbaria R, Levy J, Sharoni Y. Lycopene in serum, skin and adipose tissues after tomato-oleoresin supplementation in patients undergoing haemorrhoidectomy or peri-anal fistulotomy. Br J Nutr 2003;90:759–66.

    Article  PubMed  CAS  Google Scholar 

  11. Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001;5:62–71.

    Article  PubMed  CAS  Google Scholar 

  12. Gill JS, Zezulka AV, Beevers DG, Davies P. Relation between initial blood pressure and its fall with treatment. Lancet 1985;1:567–9.

    Article  PubMed  CAS  Google Scholar 

  13. Oldham P. The interpretation of numerical data. Measurement in medicine. London: London English Universities Press; 1968. p. 148–52.

    Google Scholar 

  14. Clinton SK. Lycopene: chemistry, biology, and implications for human health and disease. Nutr Rev 1998;56:35–51.

    Article  PubMed  CAS  Google Scholar 

  15. Stahl W, Schwarz W, Sundquist AR, Sies H. Cis–trans isomers of lycopene and beta-carotene in human serum and tissues. Arch Biochem Biophys 1992;294:173–7.

    Article  PubMed  CAS  Google Scholar 

  16. Rock CL, Swendseid ME, Jacob RA, McKee RW. Plasma carotenoid levels in human subjects fed a low carotenoid diet. J Nutr 1992;122:96–100.

    PubMed  CAS  Google Scholar 

  17. Willcox JK, Catignani GL, Lazarus S. Tomatoes and cardiovascular health. Crit Rev Food Sci Nutr 2003;43:1–18.

    Article  PubMed  CAS  Google Scholar 

  18. Morris CD, Carson S. Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2003;139:56–70.

    PubMed  CAS  Google Scholar 

  19. Rissanen TH, Voutilainen S, Nyyssonen K, Salonen R, Kaplan GA, Salonen JT. Serum lycopene concentrations and carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr 2003;77:133–8.

    PubMed  CAS  Google Scholar 

  20. Gianetti J, Pedrinelli R, Petrucci R, Lazzerini G, De Caterina M, Bellomo G, et al. Inverse association between carotid intima–media thickness and the antioxidant lycopene in atherosclerosis. Am Heart J 2002;143:467–74.

    Article  PubMed  CAS  Google Scholar 

  21. Pickering TG. What should we advise our patients about taking antioxidants? J Clin Hypertens 2003;5:231–3.

    Article  Google Scholar 

  22. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 2000;20:2175–83.

    PubMed  CAS  Google Scholar 

  23. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001;104:2673–8.

    Article  PubMed  CAS  Google Scholar 

  24. Conlin PR, Chow D, Miller ER 3rd, Svetkey LP, Lin PH, Harsha DW, et al. The effect of dietary patterns on blood pressure control in hypertensive patients: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Am J Hypertens 2000;13:949–55.

    Article  PubMed  CAS  Google Scholar 

  25. HOPE-TOO results: vitamin E supplements do not protect against cancer or cardiovascular disease. Nat Clin Pract Cardiovasc Med. 2005;2:233.

    Google Scholar 

  26. Czernichow S, Bertrais S, Blacher J, Galan P, Briancon S, Favier A, et al. Effect of supplementation with antioxidants upon long-term risk of hypertension in the SU.VI.MAX study: association with plasma antioxidant levels. J Hypertens 2005;23:2013–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Author notes

  1. Victor Novack

    Present address: Trial Design & Development, Harvard Clinical Research Institute (HCRI), Boston, MA, USA

Authors and Affiliations

  1. Hypertension Unit, Soroka University Hospital, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheba, 84101, Israel

    Esther Paran & Yechiel Nir Engelhard

  2. Division Medicine, Soroka University Hospital, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheba, Israel

    Victor Novack

  3. Hypertension Research Laboratory and Department of Biochemistry, Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheba, Israel

    Inbal Hazan-Halevy

Authors
  1. Esther Paran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Victor Novack
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yechiel Nir Engelhard
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Inbal Hazan-Halevy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Esther Paran.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paran, E., Novack, V., Engelhard, Y.N. et al. The Effects of Natural Antioxidants from Tomato Extract in Treated but Uncontrolled Hypertensive Patients. Cardiovasc Drugs Ther 23, 145–151 (2009). https://doi.org/10.1007/s10557-008-6155-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10557-008-6155-2

Key words

Search

Navigation